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Background: Post-transcriptional processing of pre-mRNA takes place in several steps and requires involvement of
a number of RNA-binding proteins. How pre-mRNA processing is regulated is in large enigmatic. The catalytic (C)
subunit of protein kinase A (PKA) is a serine/threonine kinase, which regulates numerous cellular processes
including pre-mRNA splicing. Despite that a significant fraction of the C subunit is found in splicing factor
compartments in the nucleus, there are no indications of a direct interaction between RNA and PKA. Based on this
we speculate if the specificity of the C subunit in regulating pre-mRNA splicing may be mediated indirectly
through other nuclear proteins.
Results: Using yeast two-hybrid screening with the PKA C subunit Cbeta2 as bait, we identified the G-patch
domain and KOW motifs-containing protein (GPKOW), also known as the T54 protein or MOS2 homolog, as an
interaction partner for Cbeta2. We demonstrate that GPKOW, which contains one G-patch domain and two KOW
motifs, is a nuclear RNA-binding protein conserved between species. GPKOW contains two sites that are
phosphorylated by PKA in vitro. By RNA immunoprecipitation and site directed mutagenesis of the PKA
phosphorylation sites we revealed that GPKOW binds RNA in vivo in a PKA sensitive fashion.
Conclusion: GPKOW is a RNA-binding protein that binds RNA in a PKA regulated fashion. Together with our
previous results demonstrating that PKA regulates pre-mRNA splicing, our results suggest that PKA phosphorylation
is involved in regulating RNA processing at several steps.
Keywords: RNA processing, phosphorylation, PKA catalytic subunit, GPKOW
Background
Post-transcriptional processing of pre-mRNA involves
splicing, editing and polyadenylation and starts as soon
as pre-mRNAs are produced at their sites of transcrip-
tion. In addition to small non-coding RNAs (snRNAs)
these processes require the activity of RNA-binding pro-
teins (RBPs) [1,2]. The discovery of the heterogeneous
nuclear ribonucleoproteins (hnRNP) and other pre-
mRNA/mRNA-binding proteins led to the identification
of the first amino acid motifs and functional domains
that confer binding to RNA [3]. RBPs, which may con-
tain one or multiple RNA-binding domains, are
important for RNA metabolism and are involved in
RNA stability, splicing, transport, cellular localization,
translation and decay [4]. The posttranscriptional RNA
regulon model suggests that functionally related mRNAs
are co-regulated by RBPs and snRNAs. This allows for a
smooth and coordinated regulation of mRNAs and pro-
tein synthesis according to specific tasks [5].
Little is known about how signal transduction path-
ways may be involved in regulating post-transcriptional
processing of pre-mRNA. For alternative splicing, it is
established that reversible phosphorylation conducts
some of these signals to the spliceosome [6]. We have
recently demonstrated that the C subunit of PKA is
located to splicing factor compartments (SFC) where it
regulates alternative pre-mRNA splicing in a cAMP-
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consisting of a regulatory (R) subunit dimer and two C
subunits, is expressed in all human cells and tissues
examined. There are four genes encoding the R subunits
RIa,R I b, RIIa, RIIb, and the C subunits Ca,C b,C g and
PrKX, respectively. Upon activation, the R subunit dimer
binds four molecules of cAMP leading to the dissocia-
tion of the C subunits and phosphorylation of relevant
substrates in the cytoplasm and the nucleus [8]. Specifi-
city of PKA signalling in the cell is thought to partly be
maintained through targeting of the R subunits to sub-
cellular organelles through A-kinase anchoring proteins
(AKAPs) [9]. How activity and specificity of the C subu-
nits are regulated after dissociation from the R subunits
and the corresponding AKAP, in addition to the
assumption that the R subunits are absent from the
nucleus is not well understood. It is however believed
that temporal and spatial regulation may involve both
phosphorylation and association of the C subunit with
different target proteins. It is well documented that the
C subunit phosphorylates and regulates the activity of a
vast number of proteins including nuclear cAMP
response element-binding proteins (CREBs) [10]. More-
over, C subunit binding proteins have also been identi-
fied, and include the cytoplasmic proteins IB [11],
Caveolin-1 [12] and p75 neurotrophin receptor (P75
NTR)
[13] as well as the nuclear proteins protein kinase inhi-
bitor (PKI) [14], homologous to AKAP95 (HA95) [15],
A-kinase-interacting protein (AKIP) [16] and heat shock
factor 1 [17].
Using yeast two-hybrid screening with the PKA Cb2
subunit as bait we identified GPKOW, also known as
MOS2 homolog or T54 protein, as an interaction part-
ner for Cb2. There is currently little knowledge about
GPKOW. We demonstrate that it is a nuclear protein
that binds RNA in a PKA-regulated fashion in vivo; indi-
cating that PKA may be involved in regulating multiple
steps in post-transcriptional processing of pre-mRNAs.
Materials and methods
Yeast two-hybrid screening
Yeast two-hybrid screen using the PKA C subunit Cb2
as bait was carried out by Dualsystems Biotech AG,
Zurich, Switzerland. The bait construct was made by
subcloning of a cDNA encoding complete Cb2i n t ot h e
pLexA-DIR (Dualsystems Biotech AG, Zurich, Switzer-
land). The bait construct was transformed into the
strain DSY-1 (MATa his3200 trp1-901 leu2-3,112 ade2
LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ GAL4)
using standard procedures [18]. Correct expression of
the bait was verified by western blotting of cell extracts
using a mouse monoclonal antibody directed against the
LexA domain (Santa Cruz Biotechnology, Santa Cruz,
California, USA). The absence of self-activation was
verified by co-transformation of the bait together with a
control prey and selection on minimal medium lacking
the amino acids tryptophan, leucine and histidine (selec-
tive medium). For the yeast two-hybrid screen, the bait
was co-transformed together with a human peripheral
blood cDNA library into DSY-1. Six point four million
transformants were screened yielding 22 transformants
that grew on selective medium. Positive transformants
were tested for b-galactosidase activity using a filter
assay [19]. Twenty one of the 22 initial positives showed
b-galactosidase activity. Library plasmids were isolated
from positive clones and assayed in a bait dependency
test with pLexAdir with Cb2 as bait plasmid and
pLexA-p53 and pLexA-laminC plasmids as control bait
encoding a LexA-laminC fusion using a mating strategy
[20]. Seventeen of the 21 positives showed b-galactosi-
dase activity when co-expressed with the bait but not
when co-expressed with the control bait, and were con-
sidered to be bait-dependent interactors. The identity of
the interactors was determined by sequencing.
Expression plasmids
D N Af o rt h en a t i v eP K As u b u n i t sC a1, Cb1, Cb2, Cb4
and RIa, in addition to the C-terminal V5-tagged Cb2,
was PCR amplified from cDNA from NT2-N cells. PCR
products were cloned into expression plasmids using the
pENTR/D-TOPO Cloning Kit (Invitrogen 45-0218) and
the mammalian expression vector pEF-DEST51 (Invitro-
gen 12285-011) by the LR Clonase reaction (Invitrogen
11791-019) according to the manufacturer. Full-length
GPKOW was PCR-amplified from Jurkat cell cDNA
using the following primers: upper GPKOW F TOPO
(5’CACCATGGCTGACTCCAAAGAGGG3’)a n d
GPKOW R (5’GTCATCATCTGTGTCACTAGG3’)f o r
constructs without stop codon or GPKOW stop R
(5’TCAGTCATCATCTGTGTCACTAG3’)f o rc o n -
structs with stop codon. The GPKOW PCR products
were cloned into expression plasmids using the pENTR/
D-TOPO Cloning Kit (Invitrogen 45-0218) and the
mammalian expression vector pEF-DEST51 (Invitrogen
12285-011) by the LR Clonase reaction (Invitrogen
11791-019) according to the manufacturer. The result-
ing plasmids expressed full-length GPKOW with or
without a C-terminal V5-tag. The plasmids for prokar-
yote expression were made by PCR-amplification of Jur-
kat cDNA using following primers: GPKOW Nde1 F
(5’TACGCATATGGCTGACTCCAAAGAGGGTGT3’)
and GPKOW C-His BamHI R (5’TACGGGATCCT-
CAGTGATGGTGATGGTGATGGTCAT-
CATCTGTGTCACTAGG3’ to introduce Nde1 and
BamHI restriction sites and a C-terminal 6 × His-tag.
Digested PCR products were cloned into the pET24b
vector (Novagen 69750). The QuickChange mutagenesis
kit (Stratagene 200524-5) was used to generate GPKOW
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sites with primers GPKOWfos176U23 (5’CACTCG-
CACGGCCGCACGGAGGC3’) and GPKOWfos176L23
(5’GCCTCCGTGCGGCCGTGCGAGTG3’)t oc h a n g e
serine to alanine at position 27. The primers GPKOW-
fos2940U26 (5’CTCATCACGGAAGGCCCTCTG-
GAATC3’) and GPKOWfos2940L26 (5’GATTCCA
GAGGGCCTTCCGTGATGAG3’) were used to changed
threonine to alanine at position 316. All primers were
bought from Sigma-Genosys and all expression plasmids
were sequenced.
Cell culture
293T cells were maintained at 37°C in humidified air
with 5% CO2 in RPMI 1640 (Sigma-Aldrich R0883) sup-
plemented with 10% foetal bovine serum (Sigma-Aldrich
F7524), 1% non-essential amino acids (GibcoBRL 11140-
035), 1% L-glutamine (Sigma-Aldrich G7513), 1%
sodium pyruvat (GibcoBRL 11360-039) and 1 × penicil-
lin-streptomycin solution (Sigma-Aldrich P4458). The
293T cells were transfected with Lipofectamine 2000
(Invitrogen 11668-019) according to the manufacturer’s
protocol. U2OS cells were grown in DMEM (Sigma-
Aldrich D6546) supplemented with 10% foetal bovine
serum (Sigma-Aldrich F7524), 1% L-glutamine (Sigma-
Aldrich G7513) and 1 × penicillin-streptomycin solution
(Sigma-Aldrich P4458). U2OS cells were transfected
with Fugene6 (Roche 11814443001) according to the
manufacturer’s protocol.
Co-immunoprecipitation
Four wells (35 mm) with transfected 293T cells were
washed in PBS and lysed by sonication in immunopreci-
pitation buffer (150 mM NaCl, 50 mM Tris pH 7.5,
0.5% Triton X-100, 1 × protease inhibitor cocktail
(Sigma P8340), 1 mM PMSF (Sigma P7626) and 1 mM
Na3VO4 (Sigma S6508)). The lysates were cleared by
centrifugation and adjusted to equal protein concentra-
tion for each experiment (between 1.5 - 3.4 μgp r o t e i n /
μl) by the Bradford method (BioRad 500-0006). The
lysates were precleared with Dynabeads Protein G (Invi-
trogen 100-04D, 1:10) before input samples were col-
lected (20 μl) and the remainder of the lysates were
added one of the following antibodies; rabbit IgG (same
amount μg as the positive immunoprecipitation anti-
body, Sigma I5006), anti-GPKOW (1.6 μg, Atlas Antibo-
dies HPA001894), anti-PKA RIa serum (6 μl)[21] or
anti-PKA Cb2 (12.8 μg, clone SNO103 from rabbit
serum)[22]. The mixture of cell lysate and antibody
were incubated at 4°C rotating over night before Dyna-
beads Protein G (1:10) were added the next day and
incubated for another hour. The samples were washed
with immunoprecipitation buffer, added SDS loading
dye and boiled for 5 minutes before immune blotting.
For samples treated with cAMP, the magnetic beads
were after washing incubated 5 min with buffer with or
without 1 mM 8-CPT (Sigma C3913) and both pellet
and the supernatant were analyzed by immunoblotting.
Dephosphorylation assay
The procedure is according to the manufacturer’s
recommendation (Sigma product P0114)[23]. Two wells
with 293T cells were washed in PBS and lysed by soni-
cation in immunoprecipitation buffer (150 mM NaCl, 50
mM Tris pH 7.5, 0.5% Triton X-100, 1 × protease inhi-
bitor cocktail (Sigma P8340), 1 mM PMSF (Sigma
P7626) and 1 mM Na3VO4 (Sigma S6508)). The lysates
were cleared by centrifugation and adjusted to equal
protein concentration (between 2.5 - 3.0 μgp r o t e i n / μl)
by the Bradford method (BioRad 500-0006). The lysates
were precleared with Dynabeads Protein G (Invitrogen
100-04D, 1:10) and incubated over night with anti-
GPKOW (0.8 μg, Atlas Antibodies HPA001894). Dyna-
beads Protein G (1:10) were added the next day and
incubated for another hour. The samples were washed
with immunoprecipitation buffer. Magnetic beads were
added 100 units of alkaline phosphatase (Sigma P0114)
i n5m MT r i sp H7 . 9 ,1 0m MN a C l ,1m MM g C l 2 and
0.1 mM DTT for 30 minutes at 30°C or left untreated
on ice. The samples were added SDS loading dye and
boiled for 5 minutes before immune blotting.
Immunoblotting
If not otherwise stated, the cells were washed in ice cold
PBS and lysed by sonication in lysis buffer (150 mM
NaCl, 50 mM Tris pH 7.5, 0.5% Triton-X100, 1 mM
Na3VO4, 1 mM PMSF and 1 × Protease Inhibitor Cock-
tail (Sigma-Aldrich P8340)). Lysates were cleared by
centrifugation at 16.000 × g for 20 minutes at 4°C.
Equal amounts of protein were separated by SDS-PAGE
and transferred to a PVDF membrane. The membrane
was blocked by drying and then rehydrated in methanol
before incubation with primary antibodies; anti-
GPKOW 0287 (1:250 dilution, Atlas Antibodies
HPA000287), anti-GPKOW1894 (1:500 dilution, Atlas
Antibodies HPA001894), anti-GPKOWB01 (1:1000 dilu-
tion, Abnova H00027238-B01), purified mouse anti-
PKAc (1:250 dilution, BD Transduction Laboratories
610981), anti-PKA RIa (1:250)[21] or anti-V5 (1:2000,
Invitrogen R960-25) for one hour at room temperature
(RT). The membrane was washed, before incubating
with the secondary antibodies; HRP conjugated goat
anti-mouse (1:2000 dilution, ICN Biomed 55563) or
HRP conjugated goat anti-rabbit (1:2000 dilution, ICN
Biomed 55689) for one hour at RT. After washing,
immunoreactive proteins were visualized using the ECL
detection system and developed using Hyperfilm or the
Syngene G:BOX imaging system.
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The procedure was performed as previously described
[7]. The following antibodies were used; primary antibo-
dies: anti-GPKOW1894 (1:100), anti-V5 (1:2000) and a
rabbit polyclonal antibody against a peptide of human
B-type lamins (1:1000)[24] and secondary antibodies:
Alexa Fluor 488 goat anti-rabbit IgG (1:400 dilution,
Invitrogen A11008) and Alexa Fluor 594 goat anti-
mouse IgG (1:400, Invitrogen A11005). To check the
specificity of the GPKOW-antibody, it was pre-incu-
bated with its blocking peptide (Atlas Antibodies, PrEST
antigen for GPKOW HPA001894).
RNA immunoprecipitation
The method is according to Rogne et al [25] with some
minor modifications. For the endogenous samples, 293T
cells were grown confluent in 150 cm
2 petri dishes (suf-
ficient for 2 samples), while four 10 cm
2 wells were
used for the transiently transfected 293T cells. Culture
medium was replaced by PBS before UV irradiation
(254 nm, 200 mJ/cm
2, twice). Cells were harvested,
washed in PBS and lysed in 300 μlI P Bb u f f e r( 1 0m M
HEPES pH 7.5, 2 mM EDTA, 10 mM KCl, 1% TX-100,
1 mM PMSF, 1 × Protease Inhibitor Cocktail (Sigma-
Aldrich P8340)) with 150 mM NaCl pr sample before
sonication. Lysates were cleared by centrifugation at
15,000 × g for 20 minutes at 4°C before addition of
0.048 U/μl (final concentration) of T1 RNase (Fermentas
EN0541) and incubation for 8 minutes at 37°C with
1000 rpm agitation. The lysates were adjusted to equal
protein concentrations and precleared with Dynabeads
Protein G (Invitrogen 100.04D) for 30 minutes at 4°C
rotating. Antibody (0.8 μg anti-GPKOW 1894 or 0.8 μg
rabbit IgG, Sigma 1-5006) and beads were incubated on
a rotator for 2 hours at 4°C followed by three washes in
IPB buffer. Supernatants were incubated with 30 μlc o n -
jugated beads for 2 hours at 4°C rotating. The immuno-
precipitated samples were washed 4 times by alternating
between 1 ml RIPA (1 × PBS, 0.05% SDS, 0.1% deoxy-
cholate, 1% NP-40, 1 × Protease Inhibitor Cocktail
(Sigma-Aldrich P8340)) and RIPA 1000 (1 × PBS, 1 mM
EDTA, 0.05% SDS, 0.1% deoxycholate, 1 M NaCl, 1%
NP-40, 1 × Protease Inhibitor Cocktail (Sigma-Aldrich
P8340)). Immunoprecipitated samples were depho-
sphorylated (0.038 U/μl calf intestinal phosphatase for
10 min, Roche 10713023001) and washed three times
w i t hB u f f e rC( 5 0m MT r i sH C l ,p H7 , 4 ,1 0m M
MgCl2, 0,5% NP-40, 1 × protease inhibitor cocktail
(Sigma-Aldrich P8340)), followed by labeling with g-
32P
ATP (2.1 μCi, Nerliens NEG502H) by polynucleotide
kinase (PNK, 0.5 U/μl NEB M0201L) phosphorylation
and further washed three times with Buffer C. All sam-
ples were resolved in FA dye and separated by electro-
phoresis on a denaturing (7 M urea) 6% polyacrylamide
(PAA) gel. Incorporated phosphate was visualized by
autoradiography. Unsaturated images from the Typhoon
9410 phosphoimager (GE Healthcare Life Sciences) were
quantified using the histogram function in Adobe
Photoshop. The lanes were manually defined with iden-
tical frames. The statistical analysis was performed with
paired students T-test in Prism GraphPad.
Protein purification
Plasmids were transformed into Rosetta 2(DE)pLys bac-
teria and grown on LB agar plates. 10-20 colonies were
picked and grown in 50 ml LB-medium over night at
37°C. The bacteria were pelleted and resuspended in
500 ml TB-medium and grown to optic density between
0.5-0.7 at 600 nm at 37°C and 150 rpm, before protein
expression was induced by 0.25 mM IPTG and further
grown for 4 hours at 25°C at 150 rpm. The bacteria
w e r el y s e di nB u f f e rA( 5 0m Ms o d i u md i h y d r o g e n
p h o s p h a t ep H7 . 5 ,0 . 2MN a C l ,5m MI m i d a z o l e ,1×
EDTA free protease inhibitor cocktail (Roche
04693132001) and 0.4 mM betamercaptoetanol) and
purified on a crude HisTrap column (GE Healthcare 11-
0004-58) using Buffer A and Buffer B (50 mM sodium
dihydrogen phosphate pH 7.5, 0.2 M NaCl, 500 mM
Imidazole, 1 × EDTA free protease inhibitor cocktail
(Roche 04693132001) and 0.4 mM betamercaptoetanol).
Fractions with the highest optical density at 280 nm
were pooled, dialyzed to Buffer C (20 mM Tris-HCl, pH
8) and further purified by ion exchange chromatography
(Resource Q, GE Healthcare 520348) at pH 8 with buf-
fer C and buffer D (20 mM Tris-HCl pH 8, 1 M NaCl).
Fractionated proteins were dialyzed to GPKOW storage
buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 ×
protease inhibitor cocktail and 0.4 mM betamercaptoe-
tanol) and stored at 4°C.
In vitro phosphorylation assay
Purified GPKOW proteins were in vitro phosphorylated
as previously described [7]. As a negative control for
phosphorylation heat-inactivated PKA Ca1 was used.
Unsaturated images from Syngene G-box and Typhoon
9400 phosphoimager were quantified by Genetools (Syn-
gene) and the statistical analysis was performed with
paired students T-test in GraphPad Prism. The values
from the phospho blot were adjusted according to the
amount of protein detected on the Coomassie Brilliant
Blue (CBB)-stained gel.
Results
To identify putative novel interaction partners of the
lymphoid tissue-enriched PKA C subunit Cb2, a human
peripheral blood cDNA library was screened using a
LexA based yeast two-hybrid system by Dual Systems
Biotech [26] (Additional files 1 and 2). Twelve bait
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dated the two-hybrid screen. Five of seventeen bait
dependent clones corresponded to the full-length ver-
sion of GPKOW according to the NCBI Gene bank
database accession number BC003148 (Figure 1A). In
addition we identified the sequence on two non-bait
dependent clones (b2 microglobulin and eukaryotic
translation elongation factor 1 alpha 1). GPKOW, which
was discovered during the mapping of chromosome
Xp11.23-22 [27], is also referred to as Protein T54 or
MOS2 homolog and got its name from the two
domains; G-patch and KOW (Figure 1A, yellow and red
boxes respectively). As defined by the ELM database,
the two KOW motifs of human GPKOW span the
amino acids 240 through 267 and 415 through 442. The
KOW regions detected here are in agreement with the
general definition of related domains identified in 1883
proteins (Pfam database). The KOW motif should
encompass approximately 27 amino acids, in which a
glycine at position 11 (position 13 in the KOW motifs
in GPKOW) should be conserved and surrounded by
alternating blocks of polar and nonpolar amino acids
[28]. One domain of GPKOW (Figure 1B) is consistent
with a G-patch domain of approximately 48 amino acids
that has been identified in 775 proteins (Pfam database).
Its consensus sequence consists of 6 highly conserved
glycines according to the following sequence; hhx(3)Gax
(2)GxGhGx(4)G, where the “h” represents bulky hydro-
phobic residues, the “a” represents an aromatic residue
and the “x(n)” represents any residues [29]. In GPKOW,
the same pattern was identified except for the fifth gly-
cine which is substituted with a glutamine. A sixth con-
served glycine is not included in the consensus
sequence, but according to Aravind and Koonin [29] it
is located as the 15th amino acid after the domain end.
GPKOW has a conserved glycine in this position.
Full-length GPKOW was cloned into the Gateway sys-
tem for eukaryote expression with and without a C-
terminal V5 tag. To identify expressed GPKOW, we
applied three polyclonal GPKOW antibodies and a V5-
antibody. This demonstrated that all antisera reacted
against the expressed proteins of the expected theoreti-
cal sizes of 52.5 kDa (full-length) and 57.5 kDa (V5-
tagged GPKOW) (Figure 1C). Anti-GPKOW1894
revealed the best titer and was reactive against both
expressed and endogenous protein and was therefore
primarily used.
To explore the binding capability of GPKOW and
PKA Cb2, we co-expressed GPKOW (wild-type (wt) or
V5- tagged) and Cb2 (wt or V5-tagged) in 293T cells
and performed cross-immunoprecipitations (Figure 2A).
This demonstrated that anti-Cb2 pulled down GPKOW-
V5 (Figure 2A lane 3) and vice versa ( F i g u r e2 Al a n e6 ) .
It should be noted that the interaction was inconsistent
since approximately 30% of the experiments demon-
strated a clear cut interaction. To control for specificity,
we co-transfected GPKOW with the PKA subunits Ca1,
Cb1 and Cb4. In none of these experiments we observed
co-immunoprecipitations (Figure 2B lanes 3, 6 and 9).
This suggested that GPKOW has a higher preference
for interacting with Cb2 compared to other well charac-
terized PKA C subunits. Despite this, due to the incon-
sistency observed in the co-immunoprecipitations
between GPKOW and Cb2, the experimental conditions
of the immunoprecipitations were tested by co-trans-
fecting Cb1 with its main endogenous receptor, PKA
RIa. Following immunoprecipitation with anti-RIa and
incubation in the presence (+) or absence (-) of 8-CPT-
cAMP we could demonstrate that anti-RIa immunopre-
cipitated Cb1 in a cAMP-dependent fashion, implying
satisfactory IP-conditions (Figure 2C). We next investi-
gated if the interaction between Cb2a n dG P K O Ww a s
influenced by altered levels of endogenous R after trans-
fection with Cb2, a situation that may have buffered the
availability of expressed Cb2. After transfecting cells
with GPKOW and Cb2 we stimulated with three differ-
ent agonists promoting dissociation of the PKA holoen-
zyme and release of the C subunits. These included the
PKA activator 8-CPT-cAMP, the adenylyl cyclase activa-
tor forskolin and prostaglandin E2 (PGE2) which is an
agonist for the receptor for E-series of prostaglandins
[30,31]. None of these treatments improved the rate of
interaction (results not shown). Based on these experi-
ments we conclude that the apparent interaction
between GPKOW and Cb2 is weak or highly volatile.
Subcellular localization of GPKOW was assessed by
immunofluorescence analysis and demonstrated a punc-
tuate distribution in the nucleus. GPKOW appeared to
be absent in the cytoplasm and nucleoli of 293T- and
U2OS cells (Figure 3, rows 1-2). To ensure specificity of
the antibody, we preincubated anti-GPKOW1894 with
its antigen (denoted as blocking peptide). This led to
complete abolishment of nuclear staining, further sub-
stantiating that the immunoreactive protein represents
endogenous GPKOW located in the nucleus (Figure 3,
row 3). To further confirm localization, we transfected
293T- and U2OS cells with full-length or V5-tagged
GPKOW and performed immunofluorescence staining
with anti-GPKOW1894 or anti-V5. This revealed that
transfected GPKOW was located to the nucleus and
appeared to be absent from the cytoplasm and nucleoli
(Figure 3, rows 4-6). It should however be mentioned
that over-expressed full-length and V5-tagged GPKOW
in 293T cells tended to accumulate at the inner surface
of the nuclear membrane, as determined by co-staining
of anti-V5 with the nuclear membrane marker anti-
lamin B (Figure 3, row 6). We did not pursue this phe-
nomenon further since it was considered a result of
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Page 5 of 14Figure 1 Sequence, domains and expression of GPKOW. A. Sequence alignment of GPKOW from human (NCBI NP_056513.2, upper line),
monkey (NCBI XP_001105674, middle line) and cattle (NCBI XP_616889, lower line). The G-patch domain is indicated in yellow and the two
KOW motifs are indicated in red. Two potential PKA phosphorylation sites, S27 and T316 (according to human GPKOW), are indicated in green.
B. The G-patch domain of GPKOW as defined in the ELM database. Upper case letters illustrate the G-patch consensus sequence, where bold
letters are glycines, underscored letters are hydrophobic residues and aromatic amino acids are marked in italic. C. 293T cells were left untreated
(lanes 1, 3 and 5) or transfected with full-length GPKOW (lanes 2, 4 and 6) or GPKOW with a C-terminal V5-tag (lane 7). U2OS cells were left
untreated (lane 8) or transfected with full-length GPKOW (lane 9). Twenty hours post transfection the cells were harvested and lysed. Eighteen
μg (lanes 1-4 and 7), 36 μg (lane 5-6) or 46 μg (lanes 8-9) of protein was loaded per lane, separated by SDS-PAGE (10% gels) and analyzed by
immunoblotting using three different GPKOW antibodies, 1894 (lanes 1-2 and 8-9), 0287 (lanes 3-4) and B01 (lanes 5-6) or V5 antibody (lane 7).
One representative immunoblot from each experiment is presented.
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Page 6 of 14Figure 2 Co-immunoprecipitations of GPKOW and PKA Cb2. A. 293T cells were transfected with native PKA Cb2a n dG P K O Ww i t haC -
terminal V5-tag (lanes 1-3) or with native GPKOW and PKA Cb2 with a C-terminal V5-tag (lanes 4-6). Twenty hours post transfection the cells
were harvested and lysed. The lysates were adjusted to equal protein concentration for each experiment and precleared with magnetic beads
before input samples were collected (lanes 1 and 4). The lysates were subjected to immunoprecipitations using anti-PKA Cb2 (lane 3), anti-
GPKOW (lane 6) or rabbit IgG (lanes 2 and 5) and magnetic beads. All samples were analyzed by SDS-PAGE and immunoblotting using anti-PKA
C (lower panel lanes 1-3), anti-GPKOW (lower panel lanes 4-6) or anti-V5 (upper panel). One representative experiment clearly showing
interaction is presented. B. 293T cells were co-transfected with native GPKOW and PKA Ca1 (lanes 1-3), PKA Cb1 (lanes 4-6) or PKA Cb4 (lanes 7-
9) and treated as described in A. Input samples (lane1, 4 and 7) and immunoprecipitations with anti-GPKOW (lane 3, 6 and 9) or rabbit IgG
(lanes 2, 5 and 8) were immunoblotted with anti-GPKOW (lower panel) or anti-PKA C (upper panel). One representative experiment is presented.
C. 293T cells were co-transfected with PKA Cb1 and PKA RIa, treated as described in A and immunoprecipitated with anti-PKA RIa (lanes 2-5).
One pellet were treated with the cAMP analog, 8-CPT (lanes 4-5), and all pellets (P) and supernatants (S) were analyzed by SDS-PAGE and
immunoblotting using anti-PKA C (upper panel) or anti-PKA RIa (lower panel). One representative experiment is shown.
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clusion was supported in that over-expressed GPKOW
in U2OS was distributed in the nucleus in the same
manner as the endogenous protein (Figure 3, row 5).
It is speculated that the G-patch domain of GPKOW
forms two a-helixes that are capable of binding single-
s t r a n d e dR N Aa n dD N Aa sw e l la sp r o t e i n s[ 2 9 , 3 2 - 3 4 ] .
In addition, it has been demonstrated that KOW motifs
contain alternating hydrophilic and hydrophobic resi-
dues that form two b-strands, which have non-
overlapping binding sites for both nucleic acids and
amino acids. The KOW motif is a close structural
homolog of the Tudor protein-protein interaction motif
[35-37]. Together this implies that GPKOW may be a
nuclear nucleic acid binding protein. To investigate this
in vivo we performed RNA immunoprecipitation. The
sample immunoprecipitated with anti-GPKOW1894
(Figure 4A, lane 2) contained significantly more (p <
0.05, n = 4) radiolabelled nucleotides than the sample
immunoprecipitated with rabbit IgG (Figure 4A, lane 1
and Figure 4B), concluding that GPKOW is a RNA-
binding protein.
We noticed two potential PKA phosphorylation sites
in human GPKOW, at serine 27 (S27) and threonine
Figure 3 Localization of GPKOW. Immunofluorescence analysis of
paraformaldehyde fixated 293T (rows 1, 4 and 6) and U2OS cells
(rows 2, 3 and 5) stained with anti-GPKOW 1894 (rows 1-5, green),
anti-V5 (row 6, red) or anti-lamin B (row 6, green). In the fourth row
the antibody was preincubated with antigen (+ blocking peptide)
before incubation. The three lower rows show anti-GPKOW and
anti-V5 staining of transfected full-length (rows 4-5) or V5-tagged
(row 6) GPKOW. Nuclear DNA was visualized with Hoechst (rows 1-
6, blue). Merged photos to the right. Scale bar, 10 μM.
Figure 4 GPKOW binds RNA in vivo. A. 293T cells were harvested
and exposed to UV irradiation (254 nm/200 mJ). The cells were
lysed and treated with T1 RNase (0.048 U/μl) for 8 min followed by
immunoprecipitation with Dynabeads conjugated with anti-
GPKOW1894 (+ anti-GPKOW, lane 2) or rabbit IgG (+ IgG, lane 1).
Immunoprecipitated samples were dephosphorylated with calf
intestinal phosphatase (0.038 U/μl). The RNA was labeled with g
32-P
ATP by PNK (0.5 U/μl) phosphorylation. All samples were separated
on a denaturating (7 M urea) 6% PAA gel and subjected to
autoradiography. The arrows indicate specific RNA species. The
lower panel shows immunoreactive GPKOW from the cell lysate
used (one representative lane is shown). B. Unsaturated images
from the Typhoon 9410 phosphoimager (GE Healthcare Life
Sciences) were quantified using the histogram function in Adobe
Photoshop. The lanes were manually defined with identical frames.
The statistical analysis was performed with paired students T-test in
GraphPad Prism. The asterisk indicates a significant difference
between the columns with a p-value < 0.05 (n = 4).
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monkey and cattle (Figure 1A, green box, ELM data-
base)[38]. Based on this observation, we characterized a
potential role of PKA in regulating GPKOW function
through phosphorylation. First we tested if PKA was
capable of phosphorylating GPKOW in vitro and further
if phosphorylation was involved in regulating GPKOWs
RNA-binding properties. Full-length GPKOW wt and
GPKOW containing mutations from serine to alanine at
position 27 (S27A) and/or threonine to alanine at posi-
tion 316 (T316A) were expressed with a C-terminal 6 ×
His-tags in bacteria. Purified proteins were analyzed by
immunoblotting using anti-GPKOWB01 and CBB stain-
ing, showing that wt and mutated proteins all migrated
with an apparent molecular mass of 52.5 kDa (Figure
5A and 5B lower panel). We next tested if the purified
GPKOW proteins could be phosphorylated by PKA in
vitro. This demonstrated that active Ca1i n c o r p o r a t e d
radiolabelled phosphate in GPKOW (Figure 5B, upper
panel, lane 2), whereas phosphorylation was abolished
when Ca1 was heat inactivated (Figure 5B, upper panel,
lane 1). In the case of the single mutations of S27A and
T316A, respectively (Figure 5B, upper panel, lanes 3-6),
phosphorylation was decreased compared to wt. For the
double mutated GPKOW (Figure 5B, upper panel, lanes
7 and 8 and Figure 5C) phosphorylation was signifi-
cantly reduced (p- < 0.01, n = 3). It appeared that both
S27 and T316 are phosphorylated by PKA Ca1 in vitro.
In these experiments the amount of the different pro-
teins was determined by immunoblot analysis (Figure
5A) and CBB staining (Figure 5B, lower panel). Longer
exposure of the gel revealed a faint bond in the double
mutant sample which corresponded to the lower of the
two bands at approximately 50 kDa seen with the CBB
staining. To investigate if GPKOW is a phospho-protein
in vivo we conducted a phosphatase treatment experi-
ment. Endogenous GPKOW from 293T cells was immu-
noprecipitated, incubated with alkaline phosphatase and
subjected to immunoblotting. This resulted in a marked
reduction in size of the phosphatase treated GPKOW
(Figure 5D), supporting that GPKOW also is phosphory-
lated in vivo.
Next, we speculated if PKA-dependent phosphoryla-
tion influenced the localization of GPKOW, as has been
demonstrated for other proteins [13,39,40]. Comparison
of the expression of wt and mutated GPKOW by immu-
nofluorescence analysis demonstrated no apparent dif-
ferences in localization as they all seemed evenly
distributed in the nucleus, but excluded from the
n u c l e o l i( F i g u r e6 A ) .T ot e s ti fm u t a t i o no ft h eP K A -
phosphorylation sites in GPKOW would influence
GPKOW function in vivo, we performed RNA immuno-
precipitaion assays with wt (Figure 6B, lanes 1 and 2)
and double mutated (Figure 6B, lanes 3 and 4)
GPKOW. This resulted in a significant increase (p <
0.01, n = 7) in radiolabelled RNA when the double
GPKOW mutant was immunoprecipitated (Figure 6C),
suggesting that PKA phosphorylation regulates the abil-
ity of GPKOW to bind RNA. Note that over-expression
of GPKOW resulted in a more profound difference
between the immunoprecipitation control (Figure 6B,
l a n e s1a n d3 )a n dt h eG P K O Ws a m p l e( F i g u r e6 B ,
lanes 2 and 4) than for the endogenous RNA immuno-
precipitation (Figure 4A).
Discussion
We have characterized the protein GPKOW and
demonstrated that it is a nuclear RNA-binding protein
which is in vitro phosphorylated by and probably asso-
ciated with the C subunit of PKA. GPKOW contains
two PKA phosphorylation sites at S27 and T316, which
by mutational analysis were shown to regulate RNA-
binding in vivo in a PKA-dependent manner. Endogen-
ous as well as expressed wt and mutated GPKOW were
all shown to locate to the nucleus, as determined by
immunofluorescence microscopy. The mechanism by
w h i c hG P K O Wl o c a t e st ot h en u c l e u si su n k n o w n .
However, based on our results, database searches and
the literature it probably does not involve PKA-depen-
dent phosphorylation, the G-patch domain or a recog-
nizable nuclear localization signal (NLS). The latter is
supported by searches using various publicly available
bioinformatics tools including PredictNLS Online, Pro-
site and PSORT, which all indicated that GPKOW does
not contain any known NLS. This was unexpected since
the GPKOW homolog, modifier of snc 1 and 2 (MOS2),
identified in Arabidopsis thaliana, has been shown to be
nuclear and contains a NLS [41]. Furthermore, the
assumption that nuclear localization of GPKOW do not
involve the G-patch domain is supported by recent
reports demonstrating that the Zebra fish Telomerase
Reverse Transcriptase (zLPTS), which is nuclear,
remained nuclear after deletion of its N-terminal G-
patch domain [42]. In addition, mutating three of the
conserved glycines in the G-patch domain of Tuftelin-
Interacting Protein 11 (TFIP11) did not change its
nuclear localization [43,44]. In the case of the PKA
phosphorylation sites, we show that over-expression of
single- or double-mutated GPKOW S27A and GPKOW
T316A does not alter their localization.
Based on experiments using RNA immumoprecipita-
tion we concluded that GPKOW binds RNA. However,
w ec a nn o tr u l eo u tt h a tt h ep u l l e dd o w nR N Am a yb e
associated with an unknown interaction partner of
GPKOW. This needs to be investigated further. We
used T1 RNase treatment of the samples prior to immu-
noprecipitation with anti-GPKOW to obtain suitable
sized RNA fragments for the electrophoresis. T1 RNase
Aksaas et al. Journal of Molecular Signaling 2011, 6:10
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Page 9 of 14is an endoribonuclease which digests RNA at G resi-
dues. This treatment of cell extracts will therefore result
in RNA species of various lengths [25,45]. Hence, a
smear of nucleotides when applying anti-GPKOW
immunoprecipitation would be expected. However,
GPKOW have 3 domains capable of binding nucleic
acids that may bind to different but distinct RNAs. That
GPKOW binds to specific RNA species finds support in
e.g. the results in lane 2 in Figure 4A and lanes 2 and 4
in Figure 6Bwhere faint but distinct RNA bands of dif-
f e r e n ts i z e sa r ed e t e c t e d .T ow h a te x t e n tt h e s eb a n d s
represent specific RNAs and hence may imply that
Figure 5 PKA phosphorylates GPKOW at S27 and T316 in vitro. A. Recombinant GPKOW proteins were expressed in bacteria and purified on
a HisTrap column followed by an ion exchange column. GPKOW wt (lane 1), GPKOW S27A (lane 2), GPKOW T316A (lane 3) and GPKOW S27A
+T316A (lane 4) were all recognized by anti-GPKOW B01 after separation on SDS-PAGE and immunoblotting. One representative immunoblot is
shown. B. Purified GPKOW wt (lanes 1 and 2), single- (lanes 3-6) or double-mutated GPKOW (lanes 7 and 8) were incubated with active (+) or
heat inactivated (-) PKA Ca1 (7.4 ng) and g-
32P-ATP in a reaction buffer. The samples were analyzed by SDS-PAGE and autoradiography. The CBB
staining in the lower panel shows the amount of the different proteins. C. Unsaturated images from Syngene G-box and Typhoon 9400
phosphoimager were quantified by Genetools (Syngene) and the statistical analysis was performed with paired students T-test in GraphPad
Prism. The asterisk indicates a significant difference between the columns with a p-value < 0.01 (n = 3). D. 293T cells were harvested and lysed.
The lysates were adjusted to equal protein concentration, precleared with magnetic beads before immunoprecipitation using anti-GPKOW (lane
1-2) and magnetic beads. Sample 2 was treated with alkaline phosphatase for 30 minutes before both samples were analyzed by SDS-PAGE and
immunoblotting using anti-GPKOW. One representative experiment is shown (n = 3).
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remains to be investigated. We can not exclude the pos-
sibility that GPKOW also binds DNA in addition to
RNA since other G-patch domain containing proteins
have been shown to be involved in DNA repair and tel-
omere maintenance [46,42,47] as well as RNA-
processing [48,49]. Furthermore, the spliceosomal pro-
tein TFIP11, which affects the splicing pattern of the
E1A minigene in vivo [43], interacts with PRP43 and in
that way promotes the release of the lariat-intron [44].
Finally, the KOW motif may also bind both RNA and
DNA in that it is frequently found in ribosomal proteins
and is proposed to have functions associated with trans-
lation [28,50-53]. To this end, a study where two con-
served residues were mutated in the KOW motif of
UpaY in Bacteriodes fragilis revealed loss of function,
suggesting a role for the KOW motif in transcriptional
termination [54].
The way in which RNA-binding of GPKOW is regu-
lated is not understood but may involve the two sites in
GPKOW for PKA-dependent phosphorylation. We pos-
tulate these sites since they were both phosphorylated
by PKA in vitro. In order to determine which site that
would be preferred by PKA we performed site-directed
mutagenesis. We observed that both single- and double-
mutation resulted in a marked decreased phosphoryla-
tion, indicating that both S27 and T316 are phosphory-
lated by PKA. The sequences surrounding GPKOWs




consensus sequences are estimated to be phosphorylated
with low efficiency by PKA [38]. Hence, it may be
argued that these sites in GPKOW are only available for
in vitro phosphorylation and not relevant in vivo.H o w -
ever, in support of biological relevance, several physiolo-
gical substrates for PKA are identified with similar
consensus phosphorylation sites. These include the
Kir1.1 renal outer medullary K
+ channel 1 and 2
(ROMK1/2 at LRKS
200 and VRTS
294)[ 5 5 - 5 7 ] ,t h eD 1
dopamine receptor (DRD1, at KRET
268) [58], Elongation
Factor-2 kinase (eEF2K or calmodulin-dependent pro-
tein kinase III at PRRS
499)[ 5 9 ]a n dH o r m o n e - s e n s i t i v e
Lipase (HSL, at MRRS
563 and PRRS
659) [60-62].
Together this supports the potential PKA-phosphoryla-
tion sites in GPKOW as genuine also in vivo.
That PKA may have regulatory effects on RNA-bind-
ing in vivo finds support in that the SR-protein serine/
arginine-rich splicing factor 1 (SRSF1) (Aksaas, Kvissel
and Skålhegg, unpublished)[63] and the hnRNP-protein
polypyrimidine tract-binding protein (PTB) [40] are
both phosphorylated by PKA. Moreover, we have
demonstrated that the C subunit of PKA is located to
SFCs and regulates alternative splice site selection in
vivo [7]. Finally, we also recently found that splicing fac-
tor arginine/serine-rich 17A (SFRS17A) is an AKAP and
may be involved in targeting PKA to SFCs [64]. In the
present work we found that GPKOW interacts with Cb2
as determined by the two-hybrid screen (five of seven-
teen bait-dependent clones) containing the main binding
partner of Cb2, the R subunit (twelve of seventeen bait
Figure 6 GPKOWs ability to bind RNA is sensitive to mutations
of its PKA phosphorylation sites. A. U2OS cells were transfected
with GPKOW wt (row 1), GPKOW S27A (row 2), GPKOW T316A (row
3) or GPKOW S27A+T316A (row 4). Cells were fixated with
paraformaldehyde 20 hours later and subjected to
immunofluorescence analysis using anti-GPKOW1894 (left, green).
Nuclear DNA was visualized with Hoechst (middle, blue). Merged
photos to the right. Scale bar 10 μM B. 293T cells transfected with
GPKOW wt (lanes 1 and 2) or GPKOW S27A + T316A (lanes 3 and 4)
were harvested and exposed to UV irradiation at 254 nm (200 mJ).
The cells were lysed and immunoprecipitated with Dynabeads
conjugated with either rabbit IgG (+ IgG, lanes 1 and 3) or anti-
GPKOW1894 (+ anti-GPKOW, lanes 2 and 4). Immunoprecipitated
samples were dephosphorylated with calf intestinal phosphatase
(0.038 U/μl) followed by labeling of RNA with PNK (0.5 U/μl)
phosphorylation. The samples were separated in a denaturating (7
M urea) 6% polyacrylamide gel and subjected to autoradiography.
The arrows indicate specific RNA species. The lower panel shows
immunoreactive GPKOW from the cell lysate used (one
representative lane is shown). n = 4 C. Unsaturated images from the
Typhoon 9410 phosphoimager (GE Healthcare Life Sciences) were
quantified using the histogram function in Adobe Photoshop. The
lanes were manually defined with identical frames. The statistical
analysis was performed with paired students T-test in GraphPad
Prism. The asterisk indicates a significant difference between the
columns with a p-value < 0.01 (n = 4).
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city of the screen. We also could demonstrate co-immu-
noprecipitation between GPKOW and Cb2. We do
however note that this interaction appeared fragile as
only about 30% of the experiments revealed a clear
result. Despite this we considered this interaction likely
since the immunoprecipitation conditions were found to
be optimal, the immunoprecipitation was not influenced
by cAMP and co-immunoprecipitations of GPKOW
with Cb1, Cb4o rC a1 were consistently negative. Since
the co-immunoprecipitation of GPKOW and Cb2w a s
not influenced by cAMP we suggest that the interaction
is independent of the R subunit, and hence that
GPKOW is not an AKAP. Rather, it should be consid-
ered a C-binding protein.
Despite that the biological role of GPKOW is
unknown, silencing of its homolog in C. Elegans
(R11A8.2) by RNAi revealed embryonic lethality [65]. In
addition to its importance for embryonic development
this result also points to GPKOW as evolutionary con-
served, which is suggestive of an important biological
role. The latter assumption is also indicated by the
importance of G-patch proteins in carcinogenesis
[66,67]. MOS2, which contains one G-patch domain and
two KOW motifs organized in the same way as
GPKOW, is involved in innate immunity via the disease
resistance genes in plants [41]. One may speculate that
MOS2 may be paralleled to downstream proteins of the
Toll-like receptor pathway in eukaryote cells [68]. In
immune cells, Toll-like receptors signal through NFB,
which has been shown to bind and activate the PKA C
subunit in a cAMP-independent fashion [11]. Cb2i sa n
immune cell-specific PKA C subunit [69] and may sug-
gest that Cb2 is associated with PKA-dependent phos-
phorylation and regulation of RNA-binding of GPKOW
r e l a t e dt oi m m u n ef u n c t i o n .T ow h a te x t e n tt h i si st h e
case remains to be investigated.
Conclusions
GPKOW is a nuclear protein with three nucleic acid
binding domains, one G-patch domain and two KOW-
motifs. We have demonstrated that GPKOW binds
RNA in vivo and that GPKOW associate with Cb2o f
PKA. GPKOWs ability to bind RNA is regulated by
PKA-dependent phosphorylation at two sites. This
implicates that PKA phosphorylation is a regulatory fac-
tor in post-transcriptional RNA processing.
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